Longitudinal health-related quality of life analysis in childhood cancer survivors after proton beam therapy

Int J Clin Oncol. 2023 Jul;28(7):928-939. doi: 10.1007/s10147-023-02353-7. Epub 2023 May 20.

Abstract

Purpose: Whilst proton beam therapy (PBT) for children with cancer is expected to reduce their comorbidities, to date only a limited number of studies have been published. To analyze the long-term comorbidity and health-related quality of life (HRQoL) of childhood cancer survivors (CCSs) after PBT, we conducted a questionnaire-based study.

Methods: Questionnaires were sent to CCSs who underwent PBT at the University of Tsukuba Hospital during the period from 1984 to 2020. Scores from 41 CCSs who did not undergo PBT (noPBT-CCSs) and from the general population were used for comparison.

Results: In total, 110 individuals who underwent PBT participated in the study. Among them, 40 individuals were longitudinally analyzed. The range of change in the scores was significantly greater in the CCSs whose initial scores were low. Although the comorbidity levels were more severe, HRQoL tended to be better in the PBT-CCSs than in the noPBT-CCSs with central nervous system (CNS) or solid tumors, respectively. When compared with the general population, the psychosocial health summary scores and its components were not different in the noPBT-CNS-CCSs. On the other hand, the psychosocial health summary scores and/or at least one of the scores of emotional, social, and school functioning were significantly higher in the other CCSs groups.

Conclusions: The HRQoL scores of CCSs with low initial scores can be greatly changed over time. Appropriate psychosocial support for this population is warranted. PBT may avoid reduction in HRQoL in terms of the psychosocial functioning of CCSs with CNS tumors.

Keywords: Childhood cancer; EuroQoL; Health-related quality of life; Long-term comorbidity; PedsQL; Proton beam therapy.

MeSH terms

  • Cancer Survivors* / psychology
  • Central Nervous System Neoplasms*
  • Child
  • Humans
  • Neoplasms* / radiotherapy
  • Proton Therapy*
  • Quality of Life / psychology
  • Survivors